title: Focal therapy will become a standard option for selected men with localized prostate cancer.
authors.affiliation: University College London; University College London Hospitals NHS Foundation Trust, London, United Kingdom; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland massimo.valerio.12@ucl.ac.uk.
authors.forename: Massimo
authors.initials: M
authors.lastname: Valerio
authors.affiliation: University College London; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
authors.forename: Mark
authors.initials: M
authors.lastname: Emberton
authors.affiliation: University College London; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
authors.forename: Hashim U
authors.initials: HU
authors.lastname: Ahmed
mesh_terms: D055011:Ablation Techniques / Q000379:methods*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000601:surgery*